Relay Therapeutics, Inc. revenue for the last year amounted to 25.55 M USD, the most of which — 25.55 M USD — came from its highest performing source at the moment, Dynamo Platform, the year earlier bringing 1.38 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Relay Therapeutics, Inc. 25.55 M USD, and the year before that — 1.38 M USD.